Hillblom Foundation, and many of his patients. He is grateful for the research support he has received from the NIH, Research Prevent Blindness, the Pritzker Family Fund, the Hellman Foundation, the Larry L. Schwartz’s current efforts are directed at developing novel therapies for age-related macular degeneration and myopic macular degeneration. OCT angiography is playing an increasingly important role in diagnosis and management of age-related macular degeneration, diabetic retinopathy, and other common retinovascular diseases. Scott Fraser and Jeff Fingler, he co-invented OCT angiography, a non-invasive means of imaging the retinal and choroidal vasculature. FDA Approved in 2017, it optimizes vision without spectacles for patients who have had cataract surgery. Robert Grubbs and Julia Kornfield at Caltech, he co-invented the Light Adjustable Lens, an intraocular lens whose power can be adjusted non-invasively using light during the post-operative period. His research focuses on developing new therapies and diagnostics for eye disease. He serves as Director of the Retina Division at the San Francisco VA Medical Center. Schwartz joined the UCSF Department of Ophthalmology in 1990. His office is not accepting new patients. He is affiliated with medical facilities Suburban Hospital and Sibley Memorial Hospital. Schwartz has extensive experience in Cardiac Electrical System Procedures, Heart Conditions, and Adult Congenital Heart Conditions. Associate Professor of Clinical Medicine. Mason School of Business’s Master of Accounting Program Daniel Schwartz, MD is a cardiology specialist in Bethesda, MD. Director, Heart Failure Program, Philadelphia VA Medical Center.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |